These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26961172)

  • 21. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.
    Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ
    Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up.
    Fici F; Seravalle G; Koylan N; Nalbantgil I; Cagla N; Korkut Y; Quarti-Trevano F; Makel W; Grassi G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):289-296. PubMed ID: 28497339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Captopril, but not nifedipine, improves endothelium-dependent vasodilation in hypertensive patients.
    Millgård J; Hägg A; Sarabi M; Lind L
    J Hum Hypertens; 1998 Aug; 12(8):511-6. PubMed ID: 9759984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice.
    Karpov YA; Gorbunov VM; Deev AD
    High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):417-25. PubMed ID: 26351011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
    Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
    Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
    Baumgart P; Reismann J; Pohlmeyer H; Düsing R
    Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
    Trials; 2015 Dec; 16():581. PubMed ID: 26686682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired capacity for stimulated fibrinolysis in primary hypertension is restored by antihypertensive therapy.
    Ridderstråle W; Ulfhammer E; Jern S; Hrafnkelsdóttir T
    Hypertension; 2006 Apr; 47(4):686-91. PubMed ID: 16520399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrogen sulfide-dependent microvascular vasodilation is improved following chronic sulfhydryl-donating antihypertensive pharmacotherapy in adults with hypertension.
    Dillon GA; Stanhewicz AE; Serviente C; Greaney JL; Alexander LM
    Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H728-H734. PubMed ID: 34477463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of coronary microvascular function after Angiotensin receptor blocker treatment with irbesartan in patients with systemic hypertension.
    Lethen H; Tries HP; Kersting S; Bramlage P; Lambertz H
    J Clin Hypertens (Greenwich); 2011 Mar; 13(3):155-61. PubMed ID: 21366846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome.
    Ghiadoni L; Bruno RM; Cartoni G; Stea F; Magagna A; Virdis A; Grassi D; Ferri C; Taddei S
    Vascul Pharmacol; 2017 May; 92():16-21. PubMed ID: 26070528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy.
    Hinoi T; Tomohiro Y; Kajiwara S; Matsuo S; Fujimoto Y; Yamamoto S; Shichijo T; Ono T
    Hypertens Res; 2008 Apr; 31(4):615-22. PubMed ID: 18633172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.
    Asayama K; Ohkubo T; Metoki H; Obara T; Inoue R; Kikuya M; Thijs L; Staessen JA; Imai Y;
    Hypertens Res; 2012 Nov; 35(11):1102-10. PubMed ID: 22895063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects.
    Lipsitz LA; Gagnon M; Vyas M; Iloputaife I; Kiely DK; Sorond F; Serrador J; Cheng DM; Babikian V; Cupples LA
    Hypertension; 2005 Feb; 45(2):216-21. PubMed ID: 15655124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy].
    Agabiti-Rosei E
    Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of one-year treatment by angiotensin converting enzyme inhibitor on baroreflex sensitivity and flow-mediated vasodilation of the brachial artery in essential hypertension--comparison with calcium channel blockers.
    Munakata M; Aihara A; Nunokawa T; Ito N; Imai Y; Ito S; Yoshinaga K
    Clin Exp Hypertens; 2003 Apr; 25(3):169-81. PubMed ID: 12716079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.